Authors: Re, G Badino, P De Angelis, I Odore, R Belloli, C

Citation: G. Re et al., Identification and coupling to adenylate cyclase of three different [H-3]CGP 12177 binding sites in Caco-2 cell membranes, PHARMAC RES, 43(4), 2001, pp. 393-398

Authors: Sambruy, Y Ferruzza, S Ranaldi, G De Angelis, I

Citation: Y. Sambruy et al., Intestinal cell culture models: Applications in toxicology and pharmacology, CELL BIOL T, 17(4), 2001, pp. 301-317

Authors: Turco, L De Angelis, I Stammati, A Zucco, F

Citation: L. Turco et al., Apoptosis evaluation in epithelial cells exposed to different chemicals: relevance of floating cells, CELL BIOL T, 16(1), 2000, pp. 53-62

Authors: Eeckhoutte, C Larrieu, G Sutra, JF Alvinerie, M Mace, K Pfeifer, A Zucco, F Stammati, AL De Angelis, I Vignoli, AL Galtier, P

Citation: C. Eeckhoutte et al., Evidence for cytochrome P4501A2-mediated protein covalent binding of thiabendazole and for its passive intestinal transport: use of human and rabbit derived cells, CHEM-BIO IN, 127(2), 2000, pp. 109-124

Authors: Klee, S Baumung, I Kluge, K Ungemach, FR Horne, E O'Keeffe, M De Angelis, I Vignoli, AL Zucco, F Stammati, A

Citation: S. Klee et al., A contribution to safety assessment of veterinary drug residues: in vitro/ex vivo studies on the intestinal toxicity and transport of covalently bound residues, XENOBIOTICA, 29(6), 1999, pp. 641-654

Authors: De Angelis, I Rossi, L Pedersen, JZ Vignoli, AL Vincentini, O Hoogenboom, LAP Polman, THG Stammati, A Zucco, F

Citation: I. De Angelis et al., Metabolism of furazolidone: alternative pathways and modes of toxicity in different cell lines, XENOBIOTICA, 29(11), 1999, pp. 1157-1169